Plain-English translation of NCT00061828 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study that follows infants diagnosed with or suspected to have biliary atresia — a rare liver disease that affects newborns. Researchers are building a national database of medical information and blood samples from infants with liver disease to learn more about how these conditions develop and progress, and to help improve care for future children.
Biliary atresia and other neonatal liver diseases are serious conditions that doctors still don't fully understand. By collecting detailed medical information and blood samples over many years, researchers hope to discover new insights that could lead to better treatments and improved outcomes for infants with these diseases.
You likely qualify if…
You likely don't qualify if…
If your infant is enrolled, you'll attend visits at a pediatric liver clinic where doctors will collect medical information and blood samples as part of routine care. Infants diagnosed with biliary atresia will be followed closely during the first year, then at 18 months, and yearly until age 10, then every two years or until liver transplant if needed. Other infants will exit the study once a diagnosis is confirmed. All your child's information will be stored securely in a national research database to help scientists study these diseases.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States